PRIMARY HYPERCHOLESTEROLEMIA
Clinical trials for PRIMARY HYPERCHOLESTEROLEMIA explained in plain language.
Never miss a new study
Get alerted when new PRIMARY HYPERCHOLESTEROLEMIA trials appear
Sign up with your email to follow new studies for PRIMARY HYPERCHOLESTEROLEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cholesterol drug shows promise in indian patients
Disease control CompletedThis study looked at how safe and effective the drug inclisiran is for Indian adults with high cholesterol or mixed dyslipidemia. Sixty-five participants received the drug as a shot under the skin. Researchers tracked side effects and measured how much LDL (bad) cholesterol dropp…
Matched conditions: PRIMARY HYPERCHOLESTEROLEMIA
Phase: PHASE4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 12:46 UTC
-
New combo pill for high cholesterol tested in nearly 2,000 patients
Disease control CompletedThis study looked at 1,839 adults with high cholesterol who were given a combination pill containing atorvastatin and ezetimibe for 24 weeks. Researchers wanted to see how well the pill lowered bad cholesterol and if it was safe in everyday medical practice. The goal was to under…
Matched conditions: PRIMARY HYPERCHOLESTEROLEMIA
Sponsor: Boryung Pharmaceutical Co., Ltd • Aim: Disease control
Last updated May 17, 2026 12:45 UTC
-
New combo pill shows promise for stubborn high cholesterol
Disease control CompletedThis study tested whether a combination of two drugs (DW5421A and DW5421B) works better than one drug alone for lowering high cholesterol. 184 adults with high cholesterol or mixed lipid problems took part. The main goal was to see how much LDL (bad) cholesterol dropped after 8 w…
Matched conditions: PRIMARY HYPERCHOLESTEROLEMIA
Phase: PHASE3 • Sponsor: Daewon Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 11, 2026 20:41 UTC
-
New combo pill tackles two heart risks at once in late-stage trial
Disease control CompletedThis study tested whether taking two experimental drugs together (BR1018B and BR1018C) can safely lower both blood pressure and LDL cholesterol better than existing treatments. 156 adults with essential hypertension and primary hypercholesterolemia took part. The goal was to see …
Matched conditions: PRIMARY HYPERCHOLESTEROLEMIA
Phase: PHASE3 • Sponsor: Boryung Pharmaceutical Co., Ltd • Aim: Disease control
Last updated May 07, 2026 18:43 UTC
-
New combo drug for blood pressure and cholesterol tested in healthy volunteers
Knowledge-focused CompletedThis study tested a new drug called BR1018, along with two other drugs (BR1018A and BR1018B), in 60 healthy adults. The goal was to see how the drugs move through the body and if they are safe. This is an early-stage study, so it does not treat any disease directly.
Matched conditions: PRIMARY HYPERCHOLESTEROLEMIA
Phase: PHASE1 • Sponsor: Boryung Pharmaceutical Co., Ltd • Aim: Knowledge-focused
Last updated May 12, 2026 13:40 UTC